Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Discover effective ways to generate income without spending any money. These tips will help you build your finances effortlessly.
23,664 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Allbirds’ shares soared 600% after a vague pivot to AI, prompting questions about hype versus substance in AI claims ...
AI's rise depends not only on chips and servers but on the cooling and mechanical systems that keep data centers aliv...
HouseWhisper unveils two AI-powered tools that automate outreach and lead routing for real estate teams. The update t...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
A new warning from the UK regulator highlights the potential risks of crypto sponsorships in soccer. Clubs, fans, and...
As bond markets flash warnings and oil risk climbs from Gulf tensions, a leading wall street strategist warns that th...
Shiba (SHIB) has entered a difficult period, with prices down roughly 65% over the past year and on-chain activity co...
Trad.Fi and W3 unveil a four-year plan to put a $650 million private-credit pipeline on blockchain rails, aiming to c...
This guide dives into Arbe's Q2 2025 earnings, decoding revenue growth, margins, and guidance. Learn actionable ways ...